Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized Phase I Dose-Escalation Trial of Carfilzomib With and Without Romidepsin in Cutaneous T-Cell Lymphoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01738594
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:35.963003+00:00
Published At
2019-08-29T00:00:00+00:00
Record Updated At
2019-08-29
Results Posted At
2019-08-29
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma", "Recurrent Mycosis Fungoides/Sezary Syndrome", "Stage I Cutaneous T-cell Non-Hodgkin Lymphoma", "Stage IA Mycosis Fungoides/Sezary Syndrome", "Stage IB Mycosis Fungoides/Sezary Syndrome", "Stage II Cutaneous T-cell Non-Hodgkin Lymphoma", "Stage IIA Mycosis Fungoides/Sezary Syndrome", "Stage IIB Mycosis Fungoides/Sezary Syndrome", "Stage III Cutaneous T-cell Non-Hodgkin Lymphoma", "Stage IIIA Mycosis Fungoides/Sezary Syndrome", "Stage IIIB Mycosis Fungoides/Sezary Syndrome", "Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma", "Stage IVA Mycosis Fungoides/Sezary Syndrome", "Stage IVB Mycosis Fungoides/Sezary Syndrome"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-08-29"
protocolSection.identificationModule.nctId
"NCT01738594"
protocolSection.identificationModule.officialTitle
"A Randomized Phase I Dose-Escalation Trial of Carfilzomib With and Without Romidepsin in Cutaneous T-Cell Lymphoma"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2019-08-29"

Study condition terms

  • Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Mycosis Fungoides/Sezary Syndrome (protocolSection.conditionsModule.conditions)
  • Stage I Cutaneous T-cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IA Mycosis Fungoides/Sezary Syndrome (protocolSection.conditionsModule.conditions)
  • Stage IB Mycosis Fungoides/Sezary Syndrome (protocolSection.conditionsModule.conditions)
  • Stage II Cutaneous T-cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IIA Mycosis Fungoides/Sezary Syndrome (protocolSection.conditionsModule.conditions)
  • Stage IIB Mycosis Fungoides/Sezary Syndrome (protocolSection.conditionsModule.conditions)
  • Stage III Cutaneous T-cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IIIA Mycosis Fungoides/Sezary Syndrome (protocolSection.conditionsModule.conditions)
  • Stage IIIB Mycosis Fungoides/Sezary Syndrome (protocolSection.conditionsModule.conditions)
  • Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IVA Mycosis Fungoides/Sezary Syndrome (protocolSection.conditionsModule.conditions)
  • Stage IVB Mycosis Fungoides/Sezary Syndrome (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.